Hybrid Ty Virus-Like Particles
- 1 January 1994
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 11 (2) , 133-141
- https://doi.org/10.3109/08830189409061721
Abstract
Vaccines need to activate antigen presenting cells, overcome genetic restriction in T-cell responses and elicit both T and B memory cells. In order to produce recombinant vaccines which can do this, considerable effort has been put into developing particulate antigen presentation systems to generate polyvalent, high molecular weight antigens which should maximally stimulate the immune system. One such antigen-carrier system is based on the ability of a protein encoded by the yeast retrotransposon, Ty, to self-assemble into virus-like particles (VLPs). Ty-fusion proteins retain this ability to form particles and a range of hybrid VLPs carrying a variety of heterologous antigens have been produced and shown to elicit potent immune responses. Hybrid VLPs carrying human immunodeficiency virus (HIV) antigens stimulate the three main components of the immune system, namely antibody synthesis, T-cell proliferative responses and cytotoxic T-lymphocyte (CTL) responses.Keywords
This publication has 29 references indexed in Scilit:
- Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.BMJ, 1991
- Purification and secondary structure determination of simaian immunodeficiency virus p27Journal of Molecular Biology, 1990
- Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMsNature, 1990
- Herman mark: A legend in his lifetimePolymers for Advanced Technologies, 1990
- An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodiesNature, 1989
- Improved immunogenicity of a peptide epitope after fusion to hepatitis B core proteinNature, 1987
- Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.BMJ, 1986
- Development of a Genetically–Engineered, Candidate Polio Vaccine Employing the Self–Assembling Properties of the Tobacco Mosaic Virus Coat ProteinNature Biotechnology, 1985
- A retrovirus-like strategy for expression of a fusion protein encoded by yeast transposon Ty1Nature, 1985
- Aetiology of AIDS—antibodies to human T-cell leukaemia virus (type III) in haemophiliacsNature, 1984